Saturday's attack is the biggest on Saudi oil infrastructure since Saddam Hussein's invasion of Kuwait in 1990.Energyread more
"Blaming Iran won't end disaster. Accepting our April '15 proposal to end war & begin talks may," Zarif said on Twitter.Energyread more
Oil prices are expected to jump as much as $10 per barrel after a coordinated drone strike hit Saudi Arabia's largest oil field, forcing the kingdom to cut its oil output in...Marketsread more
Apple's new iPhones can still send texts, download apps, and make video calls, but the company spends a lot of time and effort marketing its new phones as powerful photography...Technologyread more
Some U.S. manufacturers say tariffs, if targeted, will help address longstanding unfair trade practices like intellectual property theft.Traderead more
The trucking industry is worth hundreds of billions of dollars per year. Uber is going after this market with Uber Freight, an online platform that matches truckers with...Technologyread more
Supporters of a $15 minimum wage ballot initiative in Florida argue the state's inflation-tied pay hikes have not gone far enough.2020 Electionsread more
Saudi Arabia shut down half its oil production Saturday after drone strikes hit the world's largest oil processing facility in an attack claimed by Yemen's Houthi rebels.Politicsread more
Trusii's hydrogen water machines were supposed to help users with their health problems, but customers claim the company is involved in a giant scam.Technologyread more
The decoupling of the world's two weightiest economies seems as inescapable as its extent and global impact remains incalculable.Politicsread more
BlackBerry has reinvented itself to become a leader in securing mobile communications and in embedded communications. Next year it plans to roll out new products. CEO John...Evolveread more
A team of researchers say they have brought scientists one step closer to safely transplanting organs from pigs into humans.
Researchers from a biotechnology startup eGenesis and several universities in China, Denmark and the United States, have used CRISP-Cas9 gene editing techniques to remove diseases that could be transmitted from pigs to humans during tissue transplants.
The research could help scientists use animals to solve the shortage of available cells, tissues, and organs, which impacts hundreds of thousands of patients around the world.
The concept of using animals to grow transplantable material for humans is called "xenotransplantation," and the team said in their study they consider it a promising solution to the problem.
"What we are trying to do is create a world where there is no shortage of organs," said eGenesis Co-Founder and Chief Scientific Officer Luhan Yang in an interview with CNBC. Yang was one of the authors of the current paper.
There are currently more than 100,000 people in the United States awaiting organ transplants, and only 20 to 30 percent of them will ever receive one, she said. eGenesis, based in Cambridge, Massachusetts, is entirely focused on furthering xenotransplantion as a viable option.
But currently, one of the main risks of these techniques is that diseases known as "porcine endogenous retroviruses (PERVs)" could be spread to people.
In their study, the team designed a CRISi PR-Cas9 construct that would shut down the parts of the pig genomes responsible for PERVs. Once they successfully engineered cells with all of the sites shut down, they used a process known as somatic nuclear transfer to implant the modified DNA in a pig egg, creating an embryo free of PERVs.
They then implanted the embryo in surrogate sows, resulting in healthy pigs that showed no signs of the viruses.
Whether or not they could actually produce a viable pig without these viruses was something of an uncertainty, Yang said. Since these kinds of viruses diseases have existed in animals for millions of years, scientists have thought removing them might have other unexpected negative consequences. But the team found no such negative effect in the pigs.
The next step for the team is to solve the problem of immune compatibility between humans and pigs — there is a risk that the human body would reject tissue introduced from another species.
eGenesis closed a $38 million series A funding round, so Yang said team members are "keeping their heads down" and focusing on their next research challenge.